HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Triheptanoin

HCID 69286
New reaction
Print
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
620-67-7
Standard SMILES
CCCCCCC(=O)OCC(COC(=O)CCCCCC)OC(=O)CCCCCC
InChIKey
PJHKBYALYHRYSK-UHFFFAOYSA-N
Molecular formula
C24H44O6
Average molar mass
428.6 g/mol
Monoisotopic mass
428.31378912

Overview

Triheptanoin is a source of heptanoate fatty acids, which can be metabolized without the enzymes of long chain fatty acid oxidation. In clinical trials, patients with long chain fatty acid oxidation disorders (lc-FAODs) treated with triheptanoin are less likely to develop hypoglycemia, cardiomyopathy, rhabdomyolysis, and hepatomegaly. Complications in lc-FAOD patients are reduced from approximately 60% to approximately 10% with the addition of triheptanoin. Triheptanoin was granted FDA approval on 30 June 2020.

Names & identifiers

Preferred name
Triheptanoin
IUPAC
2,3-di(heptanoyloxy)propyl heptanoate
English name
TRIHEPTANOIN
Molecular formula
C24H44O6
Molecular weight
428.6

Names & synonyms

Triheptanoin620-67-7TrienanthoinTrioenanthoinTriheptylinGlycerol triheptanoateHeptanoin, tri-Triheptanoic glycerideDermofeel TC 7DojolviGLYCERYL TRIHEPTANOATEglyceroltriheptanoate
Show more names
C7 oilTRIOENANTHINTRIHEPTANIONtri-heptanoiC7 fatty acid
2,3-di(heptanoyloxy)propyl heptanoateUX007Dub thgDermofeel tc-7Radiamuls 2375Lanol 37 ttriheptanoinatriheptanoine

Database identifiers

CAS
620-67-7
PubChem CID
69286
DTXSID
DTXSID40862306
ChEMBL
CHEMBL4297585
UNII
2P6O7CFW5K
EC Number
210-647-2
Nikkaji
J53.997J

Properties

Computed structural properties

XLogP
7.3
Topological polar surface area
78.9 Ų
Hydrogen bond donors
0
Hydrogen bond acceptors
6
Rotatable bonds
23
Heavy atoms
30
Formal charge
0
Complexity
421

Experimental & physicochemical properties

DrugsPharmaceuticals -> Listed in ZINC15
Cosmetics · 2 items

Cosmetic ingredients (Triheptanoin) -> CIR (Cosmetic Ingredient Review)

Skin conditioning; Surfactant

Human Drugs · 2 items

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Physicochemical properties

Boiling point
200 °C · 200 °C(Press: 1 Torr)
Density
0.966 g/mL · 0.966 g/mL at 20 °C(lit.)
refractive index
20 · n20/D 1.444
storage temp.
-20 °C, · Store at -20°C, protect from light
solubility
30 mg/ml; · DMF: 30 mg/ml; DMSO: 30 mg/ml; Ethanol: 30 mg/ml
form
A liquid
color
Colorless to light yellow
Viscosity
20 mm2/s · 20mm2/s

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 5 items

This chemical does not meet GHS hazard criteria for 62.1% (64 of 103) of all reports.

Warning

H315 (37.9%): Causes skin irritation [Warning Skin corrosion/irritation]

P264, P273, P280, P302+P352, P321, P332+P317, P362+P364, P391, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 103 reports by companies from 3 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Hazard information

Regulatory Information · 3 items

PMN - indicates a commenced PMN (Pre-Manufacture Notices) substance.

REACH registered substance: Propane-1,2,3-triyl trisheptanoate (EC: 210-647-2)

Triheptanoin: Does not have an individual approval but may be used under an appropriate group standard

Hazard Classes and CategoriesSkin Irrit. 2 (37.9%)

Toxicology

Hepatotoxicity · 1 item

Serum enzyme elevations during triheptanoin therapy are frequent, mostly reflecting the underlying condition of muscle and hepatic accumulation of toxic fatty acid products and lack of adequate energy production. Elevations in CPK were present in 81%, ALT in 72% and AST in 68% of subjects treated in preregistration studies. The elevations were greater than 5 times the upper limit of normal (ULN) of CPK in 47%, ALT in 24% and AST in 15%. Nevertheless, the changes were not considered due to the triheptanoin or MCT therapy but rather to the underlying metabolic disorder and mitochondrial dysfunction. In small trials of triheptanoin in other genetic metabolic diseases, laboratory values were reported to be unchanged during supplementation. Since its approval and more widescale use, there have been no published cases of clinically apparent liver injury attributed to triheptanoin therapy, although its total clinical experience with its use has been limited.

Chemistry & industry

Pharmacology

ATC Code · 2 items

A - Alimentary tract and metabolism

QA - Alimentary tract and metabolism

Protein BindingTriheptanoin is approximately 80% protein bound in plasma, likely serum albumin.
Pharmacodynamics · 1 item

Triheptanoin is a source of medium chain fatty acids for patients with lc-FAODs. It has a moderate duration of action and a wide therapeutic window. Patients should be counselled regarding the risk of feeding tube dysfunction and intestinal malabsorption due to pancreatic insufficiency.

Mechanism of Action · 1 item

Triheptanoin is a source of heptanoate fatty acids, which can be metabolized without the enzymes of long chain fatty acid oxidation. In clinical trials, patients with lc-FAODs treated with triheptanoin experienced improvements in hypoglycemia, cardiomyopathy, and rhabdomyolysis.

Biological Half-LifeDue to multiple peak concentrations of the heptanoate metabolite, the half life of triheptanoin could not be determined.
Metabolism/MetabolitesTriheptanoin is hydrolysed to heptanoate, which can be further metabolized to β-hydroxypentanoate or β-hydroxybutyrate.
FDA Pharmacological Classification · 6 items

2P6O7CFW5K

TRIHEPTANOIN

Established Pharmacologic Class [EPC] - Medium-chain Triglyceride

Chemical Structure [CS] - Triglycerides

Triheptanoin is a Medium-chain Triglyceride.

TRIHEPTANOIN

Absorption, Distribution and Excretion · 3 items

A single 0.3 g/kg dose of triheptanoin reaches a Cmax of 178.9 µmol/L, with a Tmax 0.5 h, and an AUC of 336.5 µmol\*h/L. A single 0.4 g/kg dose of triheptanoin reaches a Cmax of 259.1 µmol/L, with a Tmax 0.8 h, and an AUC of 569.1 µmol\*h/L.

Related reactions

0 records
New reaction record
No related reactions yet

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Stability
Stable. Incompatible with strong oxidizing agents.
Cosmetics Ingredients Functions
SKIN CONDITIONING - OCCLUSIVEVISCOSITY CONTROLLING
InChI
InChI=1S/C24H44O6/c1-4-7-10-13-16-22(25)28-19-21(30-24(27)18-15-12-9-6-3)20-29-23(26)17-14-11-8-5-2/h21H,4-20H2,1-3H3
InChIKey
PJHKBYALYHRYSK-UHFFFAOYSA-N
SMILES
C(OC(=O)CCCCCC)C(OC(=O)CCCCCC)COC(=O)CCCCCC
LogP
8.86 at · 8.86 at 22℃
CAS DataBase Reference
620 · 620-67-7
EWG's Food Scores
1 · 1
FDA UNII
2 P6O7CFW5K · 2P6O7CFW5K
ATC code
16 AX17 · A16AX17
EPA Substance Registry System
1 · Heptanoic acid, 1,1',1''-(1,2,3-propanetriyl) ester (620-67-7)
UNSPSC Code
23201100 · 23201100
NACRES
77 · NA.77
Symbol(GHS)
7 · GHS07
Signal word
Warning
Hazard statements
315 · H315-H319
Precautionary statements
264 · P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313
Hazard Codes
Xi
Risk Statements
38 · 38
WGK Germany
1 · 1
RTECS
2660000 · MB2660000
TSCA
TSCA listed
Storage Class
11 · 11 - Combustible Solids
Toxicity
50 intravenous · LD50 intravenous in mouse: 320mg/kg
REACH Registrations
Active
Toxicity SummarySafe in the present practices of use and concentration. Ingredient, concentration, and use information are available in documents discoverable at https://cir-reports.cir-safety.org
Drug Induced Liver Injury · 6 items

Drug Induced Liver Injury Rank (DILIrank 2.0)

Triheptanoin

vNo-DILI-concern

0

No match

DOI:10.1016/j.drudis.2016.02.015

Safety data

wgk
1
tsca
TSCA listed
rtecs
MB2660000
Toxicity
LD50 intravenous in mouse: 320mg/kg
risk_code
38
Signal word
Warning
Symbol(GHS)
GHS07
hazard_code
Xi
Storage Class
11 - Combustible Solids
Hazard statements
H315-H319
REACH Registrations
Active
Precautionary statements
P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313

Triheptanoin is minimally eliminated in the urine.

A single dose of 0.3 g/kg results in a mean apparent clearance of 6.05 L/h/kg for heptanoate. A single dose of 0.4 g/kg results in a mean apparent clearance of 4.31 L/h/kg for heptanoate.

Uses & manufacturing

UsesCIR ingredient: Triheptanoin
Household ProductsInformation on 3 consumer products that contain Triheptanoin in the following categories is provided:
Use ClassificationCosmetics -> Skin conditioning; Surfactant
General Manufacturing InformationHeptanoic acid, 1,1',1''-(1,2,3-propanetriyl) ester: ACTIVE

Applications

Usestriheptanoin is a triglyceride that acts as a surfactant and skinconditioning agent, it also helps increase product viscosity. often used in cleansers, face and neck products, moisturizers and lipsticks.